Costs and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): a matched prospective cohort study

[1]  R. Krause,et al.  Which lumen is the source of catheter-related bloodstream infection in patients with multi-lumen central venous catheters? , 2013, Infection.

[2]  B. van Benthem,et al.  Catheter application, insertion vein and length of ICU stay prior to insertion affect the risk of catheter-related bloodstream infection. , 2012, The Journal of hospital infection.

[3]  Stephan Harbarth,et al.  The Importance of Good Data, Analysis, and Interpretation for Showing the Economics of Reducing Healthcare-Associated Infection , 2011, Infection Control & Hospital Epidemiology.

[4]  G. Rücker,et al.  Representativeness of the Surveillance Data in the Intensive Care Unit Component of the German Nosocomial Infections Surveillance System , 2010, Infection Control & Hospital Epidemiology.

[5]  S. Devriese,et al.  Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. , 2010, The Journal of hospital infection.

[6]  E. Perencevich,et al.  Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. , 2010, Archives of internal medicine.

[7]  E. Tacconelli,et al.  Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. , 2009, The Journal of hospital infection.

[8]  N. Graves,et al.  The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. , 2008, American journal of infection control.

[9]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[10]  N. Graves,et al.  Attributable Cost and Length of Stay for Patients With Central Venous Catheter—Associated Bloodstream Infection in Mexico City Intensive Care Units A Prospective, Matched Analysis , 2007, Infection Control & Hospital Epidemiology.

[11]  C. Hollenbeak,et al.  Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital* , 2006, Critical care medicine.

[12]  Johan Decruyenaere,et al.  Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  V. Rosenthal,et al.  The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. , 2003, American journal of infection control.

[14]  H. Rüden,et al.  Five years working with the German nosocomial infection surveillance system (Krankenhaus Infektions Surveillance System). , 2003, American journal of infection control.

[15]  G. B. Orsi,et al.  Hospital-Acquired, Laboratory-Confirmed Bloodstream Infection: Increased Hospital Stay and Direct Costs , 2002, Infection Control & Hospital Epidemiology.

[16]  M. Higgins,et al.  The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. , 1999, American journal of respiratory and critical care medicine.

[17]  Didier Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[18]  T. Jackson,et al.  Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004. , 2008, The Journal of hospital infection.

[19]  M. Struelens,et al.  Costs associated with hospital-acquired bacteraemia in a Belgian hospital. , 2005, The Journal of hospital infection.